Karuna Therapeutics KRTX 深 沪
等待开盘 08-28 09:30:00 美东时间
329.83
0.000
0.00%
华盛通- 最 高--
- 今 开--
- 成交量 0股
- 最 低 --
- 昨 收 329.83
- 总市值 1259.93万
- 52周最高 329.99
- 市盈率 静 --
- 换手率 0.00%
- 52周最低 158.375
- 委 比 0.00%
- 总股本 3.82万
- 历史最高 329.99
- 量 比 0
- 振 幅 0.00%
- 历史最低 11.24
- 每 手 1
- 风险率 65.55%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多药物受理最新动态：Karuna Therapeutics, Inc., a Bristol Myers Squibb CompanyBMS-986519肠溶胶囊进口申请获受理
国家药品监督管理局药品审评中心数据显示，2026年5月13日，Karuna Therapeutics, Inc., a Bristol Myers Squib...
05-13 07:15
Harmony Biosciences Announces The Appointment Of Peter Anastasiou As Chief Operating Officer
Appointments support Harmony's next phase of growth and long‑term value creationHarmony Biosciences Holdings, Inc. (NASDAQ:HRMY) today announced the appointment of Peter Anastasiou as Chief Operating Officer and updates
04-02 20:11
Kyverna Therapeutics Appoints Biotech Leaders Sravan Emany and Andrew Miller to Board of Directors
Kyverna Therapeutics announced the appointments of Sravan K. Emany and Andrew Miller, Ph.D., to its Board of Directors. Mr. Emany brings extensive financial and strategic leadership experience, while Dr. Miller adds expertise in clinical development and product approval. Their加入 strengthens the company as it advances toward commercialization and long-term success in autoimmune CAR T therapies.
02-24 13:00
聚焦中概 | 热门中概股走势分化！再鼎医药大涨超6%；霸王茶姬跌近3%
热门中概股走势分化！再鼎医药大涨超6%，抗精神分裂症新药国内获批上市；拼多多、贝壳涨超1%；霸王茶姬跌近3%，金山云、网易、哔哩哔哩跌超1%>>
2025-12-24 23:44
Karuna Therapeutics Advances Alzheimer’s Psychosis Treatment with KarXT Study
Karuna Therapeutics, Inc. (($KRTX)) announced an update on their ongoing clinic...
2025-08-16 00:24
